# Stromal Vascular Fraction (SVF) for Treatment of Enterocutaneous Fistula (HULPUTC)

> **NCT01584713** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Instituto de Investigación Hospital Universitario La Paz** · enrollment: 10 (estimated)

## Conditions studied

- Enterocutaneous Fistula

## Interventions

- **DRUG:** Adipose-derived stem cells without expanded

## Key facts

- **NCT ID:** NCT01584713
- **Lead sponsor:** Instituto de Investigación Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2012-07
- **Final completion:** 2013-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2012-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01584713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01584713, "Stromal Vascular Fraction (SVF) for Treatment of Enterocutaneous Fistula (HULPUTC)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01584713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*